Bruce Jancin Archives - Page 6 of 10

News
Ticagrelor reversal agent looks promising
March 28, 2019
NEW ORLEANS – Ticagrelor’s antiplatelet effect was squelched within 5 minutes.
News
Five pitfalls in optimizing medical management of HFrEF
March 8, 2019
SNOWMASS, COLO. – “A key message is that stability is an illusion in patients with symptomatic heart failure.” – Dr. Akshay S. Desai
News
Infective endocarditis isn’t what it used to be
March 6, 2019
Epidemiology and clinical expression of infective endocarditis are now far different from what most physicians encountered in training.
News
SGLT2 inhibitors morph into HF drugs
February 7, 2019
“We’re increasingly moving to an age where these agents are actually cardiovascular drugs that happen to lower blood glucose.” – Dr. Akshay S. Desai
News
Aspirin for primary cardiovascular prevention, RIP
January 30, 2019
SNOWMASS, COLO. – “Is aspirin safe and effective for primary prevention? The short answer here is no.” –Dr. Patrick T. O’Gara
News
Subclinical hypothyroidism boosts immediate risk of heart failure
January 24, 2019
CHICAGO – Large Danish study links subclinical and overt hypothyroidism to immediate risk of heart failure.
News
Obesity paradox applies to post-stroke mortality
January 17, 2019
CHICAGO – Overweight and obese VA stroke patients have lower 30-day and 1-year all-cause mortality after an in-hospital stroke.
News
Phone app diagnoses STEMI nearly as well as ECG
December 7, 2018
CHICAGO – With some tweaking, the AliveCor app could improve outcomes by speeding up diagnosis and treatment.
News
PIONEER-HF called “practice changing” for acute decompensated heart failure
November 12, 2018
CHICAGO – In-hospital initiation of sacubitril/valsartan safely and significantly reduced heart failure rehospitalizations in the next 8 weeks.
Video
PIONEER-HF secures place for sacubitril/valsartan in this heart failure doc’s practice
November 11, 2018
CHICAGO – The designated discussant for the PIONEER-HF presentation points out the importance of the results.